Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study

Wilko Spiering*, Bryan Williams, Jan Van der Heyden, Monique van Kleef, Rob Lo, Jorie Versmissen, Adriaan Moelker, Abraham Kroon, Hannes Reuter, Gary Ansel, Gregg W. Stone, Mark Bates, CALM-FIM EUR Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2655-2661
Number of pages7
JournalLancet
Volume390
Issue number10113
DOIs
Publication statusPublished - 16 Dec 2017

Keywords

  • ACTIVATION THERAPY
  • RENAL DENERVATION
  • CONTROLLED-TRIAL
  • BLOOD-PRESSURE
  • DOUBLE-BLIND
  • STIMULATION
  • PLACEBO
  • DISEASE

Cite this

Spiering, W., Williams, B., Van der Heyden, J., van Kleef, M., Lo, R., Versmissen, J., Moelker, A., Kroon, A., Reuter, H., Ansel, G., Stone, G. W., Bates, M., & CALM-FIM EUR Investigators (2017). Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study. Lancet, 390(10113), 2655-2661. https://doi.org/10.1016/S0140-6736(17)32337-1